Femoral head infarction: a case-control study of a rare complication

Guanying Gao1, Rongge Liu1, Yichuan Zhu1

  • 1Department of Sports Medicine, Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.

Abstract

Insights

Femoral head infarction (FHI) is a rare complication after hip arthroscopy, affecting 2.7% of patients. Lower BMI increases FHI risk, leading to poor clinical outcomes and no significant improvement in patient-reported scores.

Area of Science:

  • Orthopedic Surgery
  • Radiology
  • Patient Outcomes

Background:

  • Hip arthroscopy is a common procedure for hip joint issues.
  • Femoral head infarction (FHI) is a potential complication following hip arthroscopy.
  • Understanding FHI prevalence and impact is crucial for patient care.

Purpose of the Study:

  • Determine the prevalence of femoral head infarction (FHI) after hip arthroscopy.
  • Identify factors contributing to FHI development.
  • Assess the impact of FHI on clinical outcomes.

Main Methods:

  • Retrospective evaluation of 372 patients undergoing hip arthroscopy (May 2014-May 2023).
  • Postoperative MRI at least one year after surgery to identify FHI.
  • Matched cohort analysis comparing FHI patients with a normal group based on sex, age, and BMI.
  • Preoperative and postoperative patient-reported outcomes (PROs) collected.

Main Results:

  • FHI was identified in 10 patients (2.7%).
  • Lower BMI was significantly associated with FHI development (P=0.008).
  • FHI patients showed poorer postoperative outcomes (mHHS, iHOT-12, VAS) compared to the normal group, with significantly fewer achieving minimal clinically important difference (MCID) or patient-acceptable symptom state (PASS).

Conclusions:

  • Femoral head infarction (FHI) is a rare but significant complication of hip arthroscopy.
  • Lower body mass index (BMI) is a risk factor for developing FHI post-surgery.
  • FHI is associated with poor clinical outcomes and limited patient-reported improvement.